Other GLP-1s and related agents Dulaglutide, exenatide and other GLP-1 RAs used primarily for diabetes generally produce modest weight loss compared with the agents above
(2022) Tirzepatide once weekly for the treatment of obesity Juan P
These drugs are designed to help with weight loss and blood sugar control, making them ideal for those struggling with obesity and type 2 diabetes
We review contraindications (personal or family history of thyroid cancer, pancreatitis, severe GI conditions)
Aim for 80100 ounces of water daily, plus electrolyte-containing beverages (coconut water, low-sugar sports drinks, or bone broth) to replace sodium, potassium, and magnesium lost through loose stools
Understanding how long peptides generally take to work provides some baseline context, though MS applications fall outside the typical use cases